The Roche press release on the “friendly” agreement is here. See AP‘s “Roche to take over Genentech“:
GENEVA (March 12)–Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn’t already own, ending a long corporate struggle with its U.S.-based cancer drug partner. [more]